METHOD FOR COMBINED TREATMENT OF NEOVASCULAR GLAUCOMA ACCOMPANYING DIABETIC OR POSTTHROMBOTIC MACULAR EDEMA IN PATIENTS WITH RESIDUAL VISION Russian patent published in 2020 - IPC A61F9/08 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, specifically to ophthalmology. For treating neovascular glaucoma accompanying the diabetic or postthrombotic macular edema in the patients with residual vision, ophthalmic examination and optical coherence tomography are performed to detect macular edema, localization and height. If observing the iris and / or angle of the anterior chamber, as well as the parameters of increased intraocular pressure, the treatment is performed, the first step of which is the introduction of a VEGF inhibitor. In 2 weeks after the first stage of treatment, the second stage of treatment is performed - transscleral cyclophotocoagulation of the ciliary body. In 2–3 weeks, panretinal laser coagulation of retina in ischemic zones is performed. If observing normal values of intraocular pressure by the second stage of treatment, panretinal laser coagulation of the retina in ischemic zones is performed.

EFFECT: method provides higher clinical effectiveness and safety, preserves residual visual functions and reduces the risk of intra- and postoperative complications.

1 cl, 2 ex